Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Metacrine and Equillium Mutually Agree to Terminate Definitive Merger Agreement

Metacrine, Inc. (NASDAQ:MTCR) and Equillium, Inc. today announced the mutual termination of their previously announced definitive merger agreement. Metacrine is continuing to evaluate all strategic opportunities.  
byBenzinga Newsdesk
December 23, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Metacrine, Inc. (NASDAQ:MTCR) and Equillium, Inc. today announced the mutual termination of their previously announced definitive merger agreement. Metacrine is continuing to evaluate all strategic opportunities.
 

Additional information regarding the termination of the definitive merger agreement is provided set forth in a Current Report on Form 8-K filed by Metacrine with the U.S. Securities and Exchange Commission today and is available at www.sec.gov and on Metacrine’s website under the heading “Investors.”

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

State Governor And Presidential Hopeful Didn’t Disclose Ties To Silicon Valley Bank: What Investors Should Know

By Chris Katje
Today, 3:16 AM
The collapse of several major U.S. banks has been among the biggest subject on investors minds since last week. The story also attracted attention from the community outside of stocks and finance due to the impact it could have on the economy and companies involved. A new report links a state governor to potentially breaking a law related to one bank’s demise.

SIVB